Reply:  by Charlson, M.E. et al.
LETTERS TO THE EDITOR 
Improvement of outcomes after coronary artery 
bypass 
To the Editor: 
We wish to draw attention to serious problems in the 
reports by Gold and associates 1" 2 regarding the effects of 
cerebral perfusion pressure on neurologic outcome after 
cardiac operations. Our first concern is that the original 
study has inadequate power to discern a difference in 
stroke outcome resulting from an intervention, inasmuch 
as there were only 248 patients in the study. This small 
sample size is combined with a stroke rate of 7.2% in the 
"control" group. This is an unexpectedly high rate, incon- 
sistent with the generally expected rate of about 3% to 5% 
or the recently reported rate of 0.8% in the Bypass 
Angioplasty Revascularization I vestigation (BARI), 3 
which was conducted in 18 centers in North America with 
perfusion pressures similar to those used in Gold's control 
group. The combination of a small sample size and an 
abnormally high event rate raises serious questions about 
the general applicability of Gold's results and almost 
certainly leads to the creation of a type I statistical error 
(i.e., finding an effect when one did not exist). With a 
stroke rate liberally assigned at approximately 5%, it 
would take an estimated 2000-patient study to detect a 
50% reduction, 4' 5 a difference less than purported to have 
been found in the 248-patient study of Gold and associ- 
ates. 
Also of serious tatistical concern is the issue of multi- 
ple comparisons. Although Gold identified the five major 
outcomes in advance, there is no license to test each one 
at the overall unadjusted alpha of 0.05, especially consid- 
ering that the outcomes are clearly strongly related and 
not mutually exclusive. Even without any adjustment, 
none of the five major outcomes howed a significant 
difference between the mean arterial pressure groups. 
Most disturbing is that selected endpoints were combined 
in post hoc analysis to create another outcome for com- 
parison (mortality + cardiac morbidity + neurologic 
morbidity). This combination, which ignored the variables 
that were similar between groups, requires a penalty for 
multiple comparisons that would place the observed if- 
ference inside the cutoff for significance. 
A final mechanistic ssue relating to the presumed effect 
of mean arterial pressure on cerebral perfusion is the 
authors' apparent ignorance of the rather large amount of 
literature regarding autoregulation f cerebral circulation 
during cardiac surgery, a subject recently reviewed by 
Schell and coworkers. 6 There is abundant information 
from many clinical studies that show clearly that cerebral 
perfusion pressure has little effect on cerebral blood flow 
in the range of pressures used in the study by Gold and 
coworkers, a Contrary to the comments of Gold, 2 this has 
been shown during hypothermic, nonpulsatile cardiopul- 
monary bypass. Similar findings have been shown in the 
more elderly patient population as well. 7 
We believe the report of Gold and coworkers that 
1118 
higher perfusion pressure during cardiopulmonary b pass 
improves outcome should be considered at best as a 
preliminary, incomplete scientific study and the conclu- 
sion in defiance of current knowledge concerning cerebral 
physiology during cardiopulmonary b pass. 
J. G. Reves, MD 
W. D. White, MPH 
D. W. Amory, MD, PhD 
Department of Anesthesiology 
Duke University Medical Cemer 
Durham, NC 27710 
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Reply to the Editor: 
The members of the Cornell Coronary Artery Bypass 
Outcomes Trial (CCABOT) Group appreciate the oppor- 
tunity to expand on the points raised by Reves and 
colleagues. The authors have raised three major concerns. 
The first issue is the "high event" rate. The overall rate of 
stroke in our cohort was 4.8%, with 7.2% occurring in the 
control group. Few studies have formally trained neuro- 
logic observers blinded to intraoperative randomization 
performing serial evaluations, as were done in our cohort. 
Our study neurologists performed neurologic evaluations 
before the operations, 24 to 28 hours after the operations, 
6 days after the operations, and 6 months after the 
operations. Such uniform surveillance has been shown 
unequivocally to increase detection rates, a
In many ways, our patients were similar demographi- 
cally and clinically to those in the Bypass Angioplasty 
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Revascularization I vestigation (BARI) trial, a However, 
we now have evidence that the stroke rate is primarily a 
function of advanced aortic atheromatous disease as 
imaged by transesophageal echocardiography. In our 
study, among patients with atheroma grades I or II, no 
strokes had occurred at 1 week after the operations, 
whereas the 1-week stroke rates were 5.5%, 10.5%, and 
45.5% for grades lII, IV, and V atheroma, respectively. 3 
Thus, if the BARI trial had higher proportions of patients 
with low-grade atheroma than our trial, this difference in 
case mix would explain the differences in rates of stroke. It 
should be emphasized that high mean arterial pressure 
and atheroma grade are independently related to out- 
come.  
The issue of multiple comparisons i  widely known; our 
colleagues, however, have provided contradictory argu- 
ments about this. They first argue that there is no license 
to test each outcome at the 0.05 level. The original sample 
size of 248 was calculated to take into account aggregate 
outcomes, a total complication rate (including mortality, 
cardiac, neurologic, and cognitive complications, and de- 
terioration in functional status) in the range of 35%, and 
an estimated elta at 20%. That is, a 20% drop in the 
incidence of any of the adverse outcomes would constitute 
a clinically important difference between the two manage- 
ment strategies. At the conclusion of our trial, confidence 
intervals were provided for each of the specific outcomes, 
as well as the aggregate outcomes, and these provide the 
best way to assess the clinical and statistical significance of 
the findings. 4 Because stroke was the most common 
adverse event, it received the greatest emphasis in the 
analysis. 
Second, they argue that the outcomes are clearly 
strongly related and not mutually exclusive. We agree. In 
fact, that is precisely why we provided the analysis of the 
combined cardiac, neurologic, and mortality rates, and 
planned to do so from the outset. After arguing that the 
outcomes are strongly related and not mutually exclusive, 
the writers argue against he combination of these out- 
comes and suggest that this combination was post hoc. As 
noted previously, this was planned from the outset, for 
that very reason. In fact, we have presented the data with 
a formal statistical analysis both ways. 
Reves and coworkers comment on the mechanistic issue 
relating mean arterial pressure and cerebral perfusion. 
The data on the relationship between cerebral perfusion 
pressure (CPP) and cerebral blood flow (CBF) (i.e., 
autoregulation) are predominantly accumulated from the 
studies involving global blood flow using the Fick princi- 
ple. Reves and coworkers have extensively contributed to 
the literature on the variability of individual blood flow- 
pressure relationships and the importance of regional 
factors in the development of neurologic injury after 
cardiopulmonary bypass (CPB). These comments are 
reflected in the following passages from their research 
group.* "The lower limit of the autoregulatory threshold 
in individual hypertensive patients will vary: therefore, a
* From Schell RM, Kern FH, Greeley WJ, Schulman SR, Frasco 
PE, Croughwell ND, et al. Cerebral blood flow and metabo- 
lism during cardiopulmonary b pass. Anesth Analg 1993; 
76(4):849-65. 
higher perfusion pressure on CPB may be required to 
assure adequate cerebral perfusion. ''5 They further com- 
ment: "Although global CBF remained intact in these 
studies, the presence of extracranial and intracranial 
obstructive vascular disease in cardiac surgery patients, 
and its impact on care, await further investigation and the 
development of better techniques to assess regional CBF 
and metabolism during CPB. ''6 "The mechanism(s) of 
increased neurologic risk, which again is unknown, may 
involve increased microemboli, cerebrovascular disease, 
and/or aberrations in cerebral autoregulation with incom- 
plete global ischemia. ''7 They add, "in those patients with 
altered autoregulation (chronic hypertension, insulin-de- 
pendent diabetes) or severe cerebrovascular disease, the 
lower level of CPP at which a change in CPP effects a 
change in CBF is unknown. The absolute CPP and pump 
flows necessary to avoid the need for compensatory 
mechanisms is likely to vary between patients and be 
altered by other factors such as temperature, hematocrit 
and anesthetic state, ''s and that "the data apply only to 
patients managed with alpha-stat blood gas strategy and to 
patients without symptoms or history of hypertension and 
neurovascular disease. ''9 
Our findings and commentary agree with many of these 
statements and were directed at the tack of data on 
regional arterial blood flow during CPB as reflected in the 
work of Reves and coworkers, as well as others. We 
sincerely appreciate the opportunity to further clarify and 
expand on these areas, as well as to address the specific 
methodologic concerns that were raised. It is only through 
continued critique and collaboration that these important 
areas can be more fully explored. 
M. E. Charlson, MD 
G. S. Hartman, MD 
J. C. Peterson, RN 
T. P. Szatrowski, MD 
P. Williams-Russo, MD 
O. W. Isorn, MD 
J. P. Gold, MD 
Albert Einstein College of Medicine 
Montefiore Medical Center 
111 East 210th St. 
Bronx, NY  10467 
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Hypertrophic obstructive cardiomyopathy 
To the Editor: 
The Journal published an article titled "Hypertrophic 
Obstructive Cardiomyopathy in Pediatric Patients: Re- 
sults of Surgical Treatment," by Theodore, Danielson, 
Feldt, and Anderson (1996;112:1589-97). I would like to 
bring to the attention of the readers our article, ~ which in 
1969 provided the longest-term follow-up of a young 
teenager with biventricular hypertensive hypertrophic 
subvalvular stenosis uccessfully treated by right ventric- 
ular septectomy. The patient and one sibling were deaf 
and mute, and the mother and three of her siblings had 
congenital heart disease. 
Nicholas J. Demos, MD 
Jersey City, NJ 07306 
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Subxiphoid tube drainage in bullectomy and lung 
volume reduction: A word of caution 
To the Editor: 
Persistent air leaks after bullectomy or lung volume 
reduction (more than 7 days) may be complicated by 
infection in the residual pleural space not yet filled by the 
remaining lung. 
Drainage of this space must therefore be effective to 
facilitate the expansion of the lung. Sometimes it is 
necessary to leave the pleural tubes in for several days 
until complete resolution of the air leak and reexpansion 
of the lung occurs. A pleural tent may help in obliterating 
this space. 
In bilateral lung volume reduction and bullectomy done 
through a median sternotomy approach, we have been 
placing chest ubes to drain each base of the lung and each 
apex. The tubes exited through the subxiphoid area, 
exactly as described by Cooper and associates, ~ and were 
placed on waterseal drainage. Recently we changed this 
exit location after a Pseudomonas eruginosa infection of 
the residual pleural cavity developed in one of our pa- 
tients. Eventually the lower end of the sternum became 
infected as well during the gradual removal of the empy- 
ema tube. 
Clinical summary. A 46-year-old man was admitted 
for severe apical bullous emphysema resulting from smok- 
ing, with moderately severe restriction of daily activities. 
Respiratory examination yielded the following results: 
forced expiratory volume in 1 second. 31% of predicted; 
forced vital capacity, 45% of predicted; total lung capac- 
ity, 101% of predicted: residual volume, 220% of pre- 
dicted: arterial oxygen tension. 84 mm Hg; arterial carbon 
dioxide tension, 33 mm Hg; and no need for supplemental 
oxygen at rest or during exercise. Bronchodilators and 
steroids were used before the operation, A fiberopdc 
bronchoscope was inserted at the beginning and at the end 
of the surgical procedure through a single-lumen endotra- 
cheal tube to clear the bronchial tree as much as possible 
of secretions. A left-sided ouble-lumen tube was other- 
wise used, and through a median sternotomy incision a 
bilateral apical bullectomy was performed with a linear 
stapler reinforced with strips of bovine pericardium. A
pleural tent was not used in this case. Amber Latex IV 
tubes, 1/~ inch × 3/~2 inch (Baxter Healthcare Corporation, 
Hospital Supply Division. Deerfield, Ill.), were used to 
drain each apex and each base of the pleural space. A total 
of four chest ubes were used and all exited at the level of 
the subxiphoid area. The basal chest ubes were removed 
a few days after the operation, but the apical chest tubes 
were left in place because of the persistence of an air leak 
and a left apical residual cavity tapproximately 10 × 8 × 
6 cm), which eventually became infected with Pseudomo- 
has aeruginosa. Ceftazidime and gentamicin were started 
without improvement in the air leak or obliteration of the 
residual cavity. Twenty-six days after the operation, a left 
osteoplasty-thoracoplasty (Bj6rk technique) from the sec- 
ond to the fifth rib was performed, a This procedure 
greatly reduced the residual cavity but did not stop the air 
leak. Two days later a solution of doxycycline and lido- 
caine was introduced into the left apical residual cavity 
through the tube drainage, and within 48 hours the air 
leak ceased. The cavity became obliterated on the twenty- 
ninth day after the operation. The chest tube was con- 
verted to an empyema tube and was slowly pulled out at a 
rate of approximately 1 inch every 2 weeks. Two months 
after discharge, a 2 × 2 cm abscess developed at the lower 
end of the sternum The abscess eventually drained pus 
infected with Pseudomonas eruginosa. This chronic infec- 
tion is now slowly resolving with dressing changes, and the 
empyema tube is almost completely removed. Surgical 
d6bridement of the bone may be necessary if the fistula to 
the sternum persists. 
As a result of this complication we now place the drains 
differently. The apical chest tubes exit from the second 
intercostal space at the level of the midclavicular line, and 
the basal chest tubes exit from the seventh to eighth 
intercostal space at the anterior axillary line. 
We favor latex tubes. Because of the possibility that 
they will be left in place for an extended period, their 
pliability is particularly convenient inasmuch as they (1) 
do not compress the adjacent lung that has to expand, (2) 
do not create decubiti at the entry site, and (3) cause less 
